Many potential drug candidates fail to advance because of a lack of clinical activity at tolerated doses or because of unmanageable toxicities. Other limitations include a deficit of drug-like ...
As a First Step Toward exiting chemicals and becoming a pure drug company, the Belgian chemicals and pharmaceuticals group UCB divested its business in alkylamines in 2003. Other chemical companies ...
WEST LAFAYETTE, Ind. - Some century-old chemistry could have a strong impact on important issues in biosensors and other nanotech devices, according to a Purdue University research group. A team led ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback